Liu Xiang, Tan Xiaona, Yu Yaozong, Niu Junfang, Zhao Bo, Wang Qiujun
Department of Anesthesiology, Hebei Medical University Third Hospital, Shijiazhuang, 050051, Hebei Province, PR China; Department of Anesthesiology, Hebei Children's Hospital, Shi Jiazhuang, 050031, Hebei Province, PR China.
Department of Neurological Rehabilitation, Hebei Children's Hospital, Shi Jiazhuang, 050031, Hebei Province, PR China.
Neuropharmacology. 2025 Mar 1;265:110266. doi: 10.1016/j.neuropharm.2024.110266. Epub 2024 Dec 14.
Perioperative neurocognitive disorders (PND) is one of the most common postoperative complications, which can lead to a harmful impact on self-dependence, longer hospital stays, increased medical costs, morbidity, and mortality amongst older adults. Microglia can modulate synapse elimination involved in the complement component protein 1q (C1q) pathway to induce cognitive dysfunction, which is significantly improved by short chain fatty acids (SCFAs) treatment. Here we investigate the effects of SCFAs treatment on PND via mediating C1q complement pathway. High-throughput sequencing of 16S rDNA from fecal samples of male SD rats was applied to assess the changes in gut microbiota. Fecal microbiota transplantation (FMT) was performed to investigate whether gut microbiota from PND rats could alter cognitive impairment. The blood from the rat tail vein was collected to measure the SCFAs concentrations. Hippocampal and brain tissue samples were obtained to perform Western blots, Golgi and immunofluorescence staining. Primary microglia treated with SCFAs or Histone deacetylase inhibitor were cultured to measure microglial activation states and the expression of acetylated histone. The 16S rDNA sequencing results showed that PND rats had the significant changes in the species diversity of the gut microbiota and the metabolite of specifc species. Gut microbiota from PND rats could alter spatial learning and memory, and meanwhile, the changed SCFAs concentrations in plasma were involved. The synapse elimination in PND rats was strikingly reversed by SCFAs treatment involved in modulation complement C1q via suppressing neuroinflammation. This suggests that a link between gut microbiota dysbiosis and cognitive function impairment is involved in synapse elimination via mediating complement C1q pathway. SCFAs treatment can alleviate PND, the mechanisms of which may be associated with regulating complement C1q pathway.
围手术期神经认知障碍(PND)是最常见的术后并发症之一,可对老年人的自我独立性、更长的住院时间、增加的医疗费用、发病率和死亡率产生有害影响。小胶质细胞可调节补体成分蛋白1q(C1q)途径中涉及的突触消除,从而诱导认知功能障碍,而短链脂肪酸(SCFAs)治疗可显著改善这种障碍。在此,我们研究SCFAs治疗通过介导C1q补体途径对PND的影响。应用对雄性SD大鼠粪便样本的16S rDNA进行高通量测序来评估肠道微生物群的变化。进行粪便微生物群移植(FMT)以研究PND大鼠的肠道微生物群是否会改变认知障碍。采集大鼠尾静脉血以测量SCFAs浓度。获取海马和脑组织样本进行蛋白质免疫印迹、高尔基染色和免疫荧光染色。培养用SCFAs或组蛋白脱乙酰酶抑制剂处理的原代小胶质细胞,以测量小胶质细胞的激活状态和乙酰化组蛋白的表达。16S rDNA测序结果表明,PND大鼠的肠道微生物群物种多样性和特定物种的代谢产物有显著变化。PND大鼠的肠道微生物群可改变空间学习和记忆,同时,血浆中SCFAs浓度的变化也参与其中。SCFAs治疗通过抑制神经炎症调节补体C1q,显著逆转了PND大鼠的突触消除。这表明肠道微生物群失调与认知功能障碍之间的联系通过介导补体C1q途径参与突触消除。SCFAs治疗可减轻PND,其机制可能与调节补体C1q途径有关。